Avidity Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 08, 2023 at 04:14 pm EST
Avidity Biosciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 52.36 million compared to USD 43.6 million a year ago. Basic loss per share from continuing operations was USD 0.71 compared to USD 0.82 a year ago. Diluted loss per share from continuing operations was USD 0.71 compared to USD 0.82 a year ago.
For the nine months, net loss was USD 151.78 million compared to USD 123.52 million a year ago. Basic loss per share from continuing operations was USD 2.11 compared to USD 2.45 a year ago. Diluted loss per share from continuing operations was USD 2.11 compared to USD 2.45 a year ago.